Oslo, Norway, 30 April 2025 – The annual general meeting of PCI Biotech Holding ASA will be held at the company’s office at Oslo Cancer Cluster Innovation Park on 22 May 2025 at 10:00am (CEST).
The notice and proposed resolutions to the annual general meeting are attached. The notice, including all appendices, will be made available at PCI Biotech’s corporate website www.pcibiotech.com.
For further information, please contact:
Ronny Skuggedal, CEO/CFO, E-mail: [email protected]
Office: +47 67 11 54 00 Mobile: +47 94 00 57 57
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Attachments
- PCI Biotech Notice of AGM 2025
- PCI Biotech Proposed resolutions for the AGM 2025
- PCI Biotech Innkalling GF 2025
- PCI Biotech Forslag til beslutninger GF 2025
